Diagnosed with AR and surgery isn’t an option?*

You may be eligible for a clinical trial involving transcatheter aortic valve replacement (TAVR).

The Christ Hospital
in Cincinnati, OH

Is accepting patients in the ALIGN-AR trial

The ALIGN-AR clinical trial will study transcatheter aortic valve replacement (TAVR) in patients with symptomatic, severe aortic regurgitation (AR) that are at high risk for surgery. In this trial, the JenaValve Trilogy® TAVR System will be used.

Diagnosed with AR and surgery isn’t an option?*

You may be eligible for a clinical trial involving transcatheter aortic valve replacement (TAVR).

Dean Kereiakes, MD

Principal Investigator:

Dean Kereiakes, MD

The Christ Hospital
ALIGN-AR Trial Location

Cincinnati, OH 45219

See All ALIGN-AR Trial Site Locations & Contact Information

See the Align-AR patient brochure for more information

Patient Brochure

*For patients that are at high risk for surgical aortic valve replacement.

Diagnosed with AR and surgery isn’t an option?*

You may be eligible for a clinical trial involving transcatheter aortic valve replacement (TAVR).